RxDoctor Payments DataLook up a doctor →

Thomas Kurian, MD

Neurology with Special Qualifications in Child Neurology · Valencia, CANPI 1356675573

Payments from drug & device makers

$26,602in general payments, 2019–2025

Across 1,294 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • UCB, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Lilly USA, LLC$1K
  • SK Life Science, Inc.$1K
  • Novartis$1K
  • plus $15K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)199$4,238
UCB, Inc.91$1,935
Teva Pharmaceuticals USA, Inc.76$1,906
Lilly USA, LLC71$1,389
SK Life Science, Inc.73$1,234
Novartis67$1,078
Neurelis, Inc.43$997
Eisai Inc.34$962
Biogen45$886
MDD US Operations, LLC61$826
Amgen35$777
Genentech USA, Inc.34$733
Pfizer30$686
TG Therapeutics, Inc.24$532
Sanofi29$511
EMD Serono, Inc.20$470
Sunovion Pharmaceuticals Inc.31$458
AstraZeneca(2 entities)22$439
Neurocrine Biosciences, Inc.15$416
Lundbeck LLC16$393
Supernus Pharmaceuticals, Inc.32$360
Octapharma USA, Inc.13$349
Biohaven Pharmaceuticals, Inc.30$340
Greenwich Biosciences, Inc.7$325
Bristol Myers Squibb18$307
Upsher-smith Laboratories LLC12$275
Alnylam Pharmaceuticals Inc.8$260
Abbott6$249
Argenx US, Inc.8$221
Tonix Medicines, Inc.11$207
Avanir Pharmaceuticals, Inc.17$178
Acorda Therapeutics, Inc9$172
Johnson & Johnson5$170
Livanova USA, Inc.8$159
Kyowa Kirin, Inc.6$152
CSL Behring7$146
Akcea Therapeutics, Inc.4$141
ANI Pharmaceuticals, Inc.5$135
Acadia Pharmaceuticals Inc6$133
Mallinckrodt Hospital Products Inc.5$130
Amneal Pharmaceuticals LLC7$129
Chiesi USA, Inc.1$100
Merz Pharmaceuticals, LLC4$99
Assertio Therapeutics, Inc.6$91
Biohaven Pharmaceutical Holding Company Ltd.4$85
Sumitomo Pharma America, Inc.4$81
Otsuka America Pharmaceutical, Inc.3$72
Impel Pharmaceuticals Inc.2$66
Almatica Pharma LLC3$65
Arbor Pharmaceuticals, Inc.3$63
Medtronic1$46
Sobi, Inc2$39
Collegium Pharmaceutical, Inc.2$37
Biomarin Pharmaceutical Inc.2$33
Vanda Pharmaceuticals Inc.1$30
Cycle Pharmaceuticals Inc2$27
Mallinckrodt Enterprises LLC1$26
Jazz Pharmaceuticals Inc.1$25
Azurity Pharmaceuticals, Inc.1$25
Promius Pharma LLC1$25

How this compares

$26,602 in reported general payments places this provider in the 75th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California →

Medicare billing

Part B allowed, 2024
$338,080
Medicare patients
560
Services billed
12,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Valencia

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →